LexDanaLexDanabeta
Inventor

ROLAND E. DOLLE

Inventor
US

Overview

4→
Patents
2025–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07KPeptides14%
Y02ATechnologies for adaptation to climate change14%
C07CAcyclic or carbocyclic compounds7%
C07DHeterocyclic compounds7%
PatentTitleYear
12,577,211Probenecid compounds for the treatment of inflammasome-mediated lung disease202612,496,297Compositions of autophagy modulating agents and uses thereof202512,421,281Cyclosporine compositions and methods of use202512,252,556Cyclosporine compositions and methods of use2025

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2025–2026Patents assigned to BACAINN BIOTHERAPEUTICS LTD (3)· patent assignee history
2025Patents assigned to DOLLE ROLAND E (1)· patent assignee history
2025Patents assigned to PAK STEPHEN (1)· patent assignee history
2025Patents assigned to PERLMUTTER DAVID (1)· patent assignee history
2025Patents assigned to SILVERMAN GARY (1)· patent assignee history
2025–2026Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BACAINN BIOTHERAPEUTICS LTD32025–2026
DOLLE ROLAND Eself12025
PAK STEPHEN12025
PERLMUTTER DAVID12025
SILVERMAN GARY12025
Locations
LocationPatentsSpan
US42025–2026